BG
ACHV icon

BlackRock Group’s Achieve Life Sciences ACHV Stock Holding History

BlackRock Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-92
Closed -$472K – 3048
2015
Q2 		$472K Sell
92
-8
-8% -$39.7K ﹤0.01% 2288
2015
Q1 		$472K Sell
100
-88
-47% -$432K ﹤0.01% 2223
2014
Q4 		$947K Buy
188
+29
+18% +$142K ﹤0.01% 1912
2014
Q3 		$932K Buy
159
+107
+206% +$743K ﹤0.01% 1834
2014
Q2 		$424K Buy
+52
New +$639K ﹤0.01% 2265
2013
Q4 		– Sell
-3
Closed -$53K – 2658
2013
Q3 		$53K Buy
+3
New +$62.1K ﹤0.01% 2702

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Group's ACHV Position: Q3 2015 in Review

BlackRock Group sold out of Achieve Life Sciences (ACHV) in Q3 2015, closing a stake of 92 shares — an estimated $472K sold.

BlackRock Group first reported a position in ACHV in Q3 2013 and held it in 6 quarters. The position peaked at $947K in Q4 2014. 45 funds tracked by Wall St. Rank hold ACHV as of Q3 2015.

  • BlackRock Group reported no remaining Achieve Life Sciences position as of Q3 2015 after selling out during the quarter.
  • BlackRock Group sold 92 Achieve Life Sciences shares in Q3 2015, an estimated $472K.
  • BlackRock Group first reported a position in Achieve Life Sciences in Q3 2013 and held it in 6 quarters.
  • BlackRock Group's Achieve Life Sciences position peaked at $947K in Q4 2014.
  • 45 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2015.

Based on BlackRock Group's 13F filing for Q3 2015, filed 13 Nov 2015.